PEGylated Proteins Market Research Report 2022-2028 | Share, Global Trends, Key Players, Growth Analysis

The PEGylated Proteins Market size is expected to grow at an annual average of 10% during 2021-2027. PEGylation is a standard procedure for non-covalent and covalent attachment of polyethylene glycol polymer chains to macrostructures, a class of drugs, and therapeutic proteins, which is observed as PEGylation (PEGylation). PEGylation improves drug stability and solubility and reduces immunogenicity by changing the electrostatic bonding, identification, and hydrophobicity of molecules. PEGylation reduces renal excretion and protein degradation, thereby lowering the dosing frequency, and increasing the tension time of the conjugate in the blood and drug stability. A variety of therapeutic peptides, proteins, and small drug molecules are PEGylated to enhance or alter pharmacokinetic parameters to benefit from different outcomes.

The following segmentation are covered in this report:

By Application

• Cancer Treatment
• Hepatitis
• Chronic Kidney Diseases
• Hemophilia
• Multiple Sclerosis
• Gastrointestinal Disorders
• Other Applications

By End-User

• Pharmaceutical & Biotechnology Companies
• CROs
• Academic Research Institutes

By Protein Type

• Colony Stimulating Factors
• Interferons
• Erythropoietin
• mAbs
• Recombinant Factor VIII
• Other Protein Type

Company Profile

• Merck KGaA
• Thermo Fisher Scientific Inc.
• NOF America Corporation
• JenKem Technology USA Inc.
• Creative PEGworks
• Celares GmbH
• Quanta BioDesign Ltd
• Amgen Inc.
• Astrazeneca PLC
• Biogen Inc.
• F. Hoffmann-La Roche Ltd

Scope of the report

The research study analyses the PEGylated Proteins Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by PEGylated Proteins Market Report

• What was the PEGylated Proteins Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the PEGylated Proteins Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.